FDA OKs First Transcatheter Tricuspid Valve Replacement
Edwards Lifesciences received approval for its Evoque tricuspid valve replacement system, the first transcatheter therapy approved in the US for tricuspid regurgitation.
Source: medscape.com
Page 10 - Structural Heart News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Structural Heart. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Structural Heart Today - Breaking & Trending Today
FDA Approves EVOQUE Tricuspid Valve Replacement System for Tricuspid Regurgitation
The FDA approval of Edwards Lifesciences EVOQUE tricuspid valve replacement system for treatment of symptomatic severe tricuspid regurgitation is the first of its kind for a transcatheter therapy.
Source: hcplive.com
Edwards' EVOQUE Valve Replacement System First Transcatheter Therapy to Earn FDA Approval for Tricuspid Valve -February 02, 2024 at 07:01 am EST
Edwards Lifesciences Corporation today announced the company’s EVOQUE tricuspid valve replacement system is the first transcatheter therapy to receive U.S. Food and Drug Administration approval...
Source: marketscreener.com
Novel Biomarkers for Aortic Stenosis Identified
Using plasma proteomics and other approaches, researchers detected circulating proteins robustly associated with AV hemodynamics and the risk for related hospitalization.
Source: medscape.com
Confluent Announces Significant Investment in ATI Nitinol Melt Expansion
SCOTTSDALE, Ariz., Jan. 25, 2024 (GLOBE NEWSWIRE) -- Confluent Medical Technologies (Confluent) announced that it has partnered with ATI to inve...
Source: businessinsider.com